Brief: Altium Capital Management Reports 9.99% Passive Stake In Sunshine Biopharma - SEC Filing
Feb 21 (Reuters) - Sunshine Biopharma Inc SBFM.O :
* ALTIUM CAPITAL MANAGEMENT, LP REPORTS 9.99% PASSIVE STAKE
IN
SUNSHINE BIOPHARMA INC AS OF FEBRUARY 13, 2024- SEC FILING
Source text for Eikon: ID:n0001999371-24-002586
Further company coverage: SBFM.O
((Reuters.Briefs@thomsonreuters.com;))